Metastatic Urinary Bladder Carcinoma on Palliative Chemotherapy Showing Rapid Progression on Interim Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Vivek Kumar Saini; Alen Elias Mammoottil; Aftab Nazar Hassan; Manish Ora; Sanjay Gambhir

doi:10.4103/ijnm.ijnm_51_21

Metastatic Urinary Bladder Carcinoma on Palliative Chemotherapy Showing Rapid Progression on Interim Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Indian J Nucl Med. 2022 Jan-Mar;37(1):105-107. doi: 10.4103/ijnm.ijnm_51_21. Epub 2022 Mar 25.

Authors

Vivek Kumar Saini¹, Alen Elias Mammoottil¹, Aftab Nazar Hassan¹, Manish Ora¹, Sanjay Gambhir¹

Affiliation

¹ Department of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.

Abstract

Bladder cancer (BC) is among the top ten most common cancer types globally. Muscle invasive BC has a high incidence of metastasis. Metastatic BC has a poor prognosis and limited treatment options. Here, we present a middle-aged man with oligometastatic BC, which was treated with palliative chemotherapy. He had significant clinical improvement. However, interim 18F-Fluorodeoxyglucose positron emission tomography/computed tomography demonstrates a rapid disease progression extensive metastasis.

Keywords: Fluorodeoxyglucose positron emission tomography/computed tomography; metastatic disease; progressive disease; treatment response evaluation; urinary bladder carcinoma.